Welcome to the October edition of The Radiology Rundown. Summer is well and truly over, the nights are closing in and 2024 is rapidly coming to an end.
Which in the world of Radiology, means only one thing…
RSNA 2024
Thanksgiving is now only a few weeks away, which means that Radiological Society of North America (RSNA) is not far behind. I’ve already written an article highlighting some new exhibitors at RSNA this year that you can find here:
So I won’t spend too long on the topic here, but in next month’s edition I will be doing a full preview of the conference, ready to read whist you’re sat in those airport waiting rooms en-route to Chicago.
Industry News
The NHS in England was given the go-ahead to use AI to improve fracture detection with X-Rays. The green light was given by the NICE – National Institute for Health and Care Excellence (NICE) for selected technologies to support detection. The solutions approved for use are Rayvolve AZmed, TechCare Alert Milvue, RBfracture Radiobotics and Boneview Gleamer.
Also in the UK, deepc announced a partnership with Artificial Intelligence Centre for Value Based Healthcare, to accelerate NHS adoption of radiology AI. Deepc will deploy their ‘deepcOS’ platform across six leading NHS Trusts, with the intention to then expand to ten.
This will provide radiology departments at those trusts with access to more than 75 regulatory-approved AI solutions, within that one platform.
Both updates are huge steps forward for AI-use within the UK healthcare sector and I’m excited to see how this evolves.
FDA / Market Approvals
- October started with ai announcing that their enterprise imaging AI platform has received CE mark. This milestone allows them to now deploy over 80 CE-marked AI applications across the EEA
- ai confirmed they have received FDA 510(k) clearance for their Echocardiography AI solution. Congrats to Joseph Sokol and team.
- Coreline Soft ft also announced this week that they have received CE MDR and UKCA certifications for AVIEW. A pivotal step for them to expand across European markets.
Funding Updates
HealthTech Market Intelligence company Signify Research Ltd, completed their £6m investment from BGF, the UK and Ireland’s most active investor, and an investor in Metric. Just like Metric Bio, they will be represented by a team at RSNA and have market specialists for all areas of Medical Imaging to support your company with data insights and market analysis.
It was a quieter than usual month for funding elsewhere in radiology, but the same cannot be said in Digital Pathology. Mindpeak and Aignostics both announced significant funding rounds this month, showing that Digital Pathology AI is becoming a bigger topic in the investment world.
Partnerships & Acquisitions
October has been a bigger month for partnerships and collaborations. Just a few that I wanted to highlight this month are:
